Download Brochure
Fill in your details to get instant access
We respect your privacy. No spam, ever.
Conference Overview
The 2026 Collocated Summit Series in Washington DC combines the Brand & IP Protection Summit and the 18th Pharma Anti-Counterfeiting, Serialization & Supply Chain Security Conference. This dual-track event brings together global industry leaders, legal experts, and regulators to address pressing cross-sector IP challenges alongside specialized pharmaceutical security strategies. Attendees will explore practical solutions, emerging technologies, and collaborative approaches to protect brand reputation, enforce compliance, and ensure supply chain integrity.
Anti-Counterfeiting
Highlights enforcement tactics, advanced forensic detection, and laboratory analysis to combat illicit and fake goods. The track emphasizes cross-agency collaboration and legal measures to safeguard products and patient health
IP Protection
Focuses on international legal frameworks, global policy alignment, and advanced licensing strategies. It explores key methods for mitigating intellectual property risks across cross-border partnerships and vendor networks.
Serialization Track & Trace
Centers on implementing track-and-trace technology, DSCSA readiness, and unique product identification rules. Sessions explore packaging design innovations and tamper-evident solutions to ensure compliance and traceability.
Brand Security
Addresses emerging global threats, digital piracy, and online brand infringement across diverse commercial sectors. Experts will discuss proactive defense strategies, consumer education, and methods for restoring trust in digital commerce.
Supply Chain
Examines ways to transform global logistics into resilient, intelligent, and risk-prepared operational networks. Discussions cover cold chain security, operational continuity, and end-to-end visibility across manufacturing and delivery channels.
Serialization Track
Centers on implementing track-and-trace technology, DSCSA readiness, and unique product identification rules. Sessions explore packaging design innovations and tamper-evident solutions to ensure compliance and traceability.
Digital Innovation
Leverages cutting-edge technologies like AI, blockchain, and real-time data analytics to modernize supply chain infrastructure. It highlights practical applications that drive efficiency, automate operations, and go beyond standard regulatory compliance.
Download Brochure
Fill in your details to get instant access
We respect your privacy. No spam, ever.
Safeguarding Innovation: The 2026 Collocated Summit Series
Welcome to the 2026 Collocated Summit Series in Washington DC, co-locating the 18th Pharma Anti-Counterfeiting, Serialization & Supply Chain Security Conference and the Brand & IP Protection Summit. Taking place on December 2–3, 2026, this flagship event unites pharmaceutical executives, legal strategists, and cross-industry brand leaders to address global supply chain risks and intellectual property threats. Featuring dual-track sessions, cross-sector panels, and high-impact networking, attendees will explore cutting-edge solutions in AI, blockchain, track-and-trace serialization, and international enforcement. Join us to gain practical insights, collaborate with regulatory authorities, and build resilient, secure supply chains for the future.
Speakers
Attendees
HOURS OF NETWORKING
SESSIONS
OUR ATTENDEES
Trusted by Industry Leaders Worldwide
REGISTER ATTEND LEARN NETWORK SUCCEED
5 reasons to attend the events
The 2026 Collocated Summit Series in Washington DC brings together global experts to address pressing brand protection, IP strategy, and pharmaceutical supply chain challenges. Attendees can seamlessly navigate dual tracks covering cross-industry IP security alongside specialized pharmaceutical track-and-trace presentations. It serves as an essential forum to discover emerging technologies, engage with key regulators, and strengthen operational resilience.
Actionable Insights
Gain practical, high-impact strategies to combat counterfeiting, manage IP risks, and achieve seamless regulatory compliance. Discover real-world case studies and forensic techniques from top industry leaders.
Elite Networking
Connect with brand owners, legal experts, government officials, and pharmaceutical executives across both tracks. Build strategic partnerships during dedicated networking receptions and interactive panel sessions
Cutting-Edge Tech
Explore advanced solutions in AI, blockchain, digital authentication, and serialization technologies. Learn how next-generation digital shields can safeguard products from end-to-end.
Regulatory Leadership
Stay ahead of evolving global standards, including DSCSA readiness and international IP policies. Hear directly from enforcement agencies like the DEA, CBP, and USPTO.
Future Resilience
Transform supply chain and brand protection models from reactive compliance into proactive, resilient frameworks. Learn proven methods to protect brand integrity, consumer safety, and market share.
Meet Our Expert Speakers
OUR EVENT SCHEDULE
Coffee and registration — Opportunity to meet and network with colleagues
Coffee and registration — Opportunity to meet and network with colleagues
09:00 Chairperson's Opening Remarks
MARK KARHOFF
Ten Count Consulting
TACKLING COUNTERFEIT DRUGS
09:10 How Pharma is Fighting Counterfeit Drugs Now?
Critical lessons to stop fake drugs, managing short implementation times.
OMAR ALI
Verpora
VINEET SINGH
CSL Behring
DETECTION / AUTHENTICATION
09:40 Advanced Analytical Technologies for the Detection & Authentication of Counterfeit Drug Products
- This presentation will describe the roles and responsibilities of the BMS forensics laboratory in combating the global counterfeiting issue.
- Real ‘suspect product’ investigations submitted to BMS will be highlighted, including a variety of counterfeit products.
- Analytical techniques will be showcased, including microscopy, spectroscopy, elemental, and chromatographic analyses.
- Portable technologies are also utilized to detect potential counterfeits in the field.
BRITTANY HANDZO
Bristol-Myers Squibb
10:20 - Topic TBC
OMAR ALI
Verpora
VINEET SINGH
CSL Behring
CHALLENGES & OPPORTUNITIES
11:20 Keynote Panel Discussion: The War Against Counterfeit Medicines: Strategies, Technology, Innovation, Enforcement & Global Collaboration for a Safer Future
- Key shifts shaping pharma access globally.
- Aligning pricing with payer, provider, and patient needs.
- Adapting pricing across regions and income levels.
- Innovative Contracting – Exploring risk-sharing and out come-based deals.
- Pricing approaches for access in developing markets.
- Future Outlook: Best practices and trends in access-driven pricing.
- Staying ahead in the race – Update on pricing and market access in USA, EU & RoW
- Implications for companies – What to Prepare for future
Moderator
Deallus
Panellists
PETER COLOSI
Gilead Sciences
LIBBY BURSTEIN
ASOP Global
SWAMINATHAN SUBRAMANIAN
Regeneron Pharmaceuticals
RYAN COELHO
Zoetis
RYAN COELHO
Zoetis
RAHUL SHENOLIKAR
AstraZeneca
RWD / RWE
12:10 - Topic TBC
- Evaluating the traditional view of market access and what contract success means
- Assess what are payers telling us about the future of Pharma contracting
- Quantifying the gaps in the Patient Journey why those gaps are larger than most teams believe
- Understanding where and why marketing, forecasting, payer contracting, and patient services break down
- A proposed model & expanded role for Market Access: What it would take to make it happen, and the impact it would have on process, product, and patient
JERRY SMITH
D2 Solutions
12:30 – Networking Luncheon
PUTTING PATIENTS FIRST
13:30 Panel Discussion with the experts – Rethinking Pharma Supply Chains: The new era with Smarter Strategies for Global Success for the future
Moderator
ODI IKPE
GS1 US
Panellists
ULLRICH MAYESKI
Jazz Pharmaceuticals
MAHFUZA AHMEDIN
AstraZeneca
CHIRAG SHAH
Sanofi
MICHAL NOWINA KONOPKA
Kedrion Biopharma
ABHISHEK AGARWAL
GSK
YAOZHU (JULIETTE) CHEN
AstraZeneca
14:20 Anti-Counterfeiting & Serialization Packaging Techniques
14:30 – What market access leaders need to know about trends in rare disease market access strategy
Incorporating design elements, tamper-evidence, and optimizing efficiencies.
JAY WEAVER
PANTHERx Rare Pharmacy
SECURING SCM
15:20 From Compliance to Resilience: The Future of Pharma Supply Chains
The session explores how pharmaceutical supply chains are evolving from primarily compliance-driven operations into more resilient, intelligent, and strategically integrated networks, including themes such as supply continuity, risk management, AI-enabled visibility, serialization beyond compliance, digital transformation, and operational resilience in increasingly complex global environments.
MICHAL NOWINA KONOPKA
(Former) Kedrion Biopharma
REGULATORY
16:00 Panel Discussion with the experts – The Future of Global Pharma Security: Smarter Regulations, Safer Medicines. Regulatory Leadership in the Fight Against Counterfeit Drugs
Moderator
VAISHALI KOTHARI
(Former) Dr. Reddy's Laboratories
Panellists
KELLY A. BELNICK
Eli Lilly
NANCY FINGERHUT
Revelation Pharma
MELISSA HAGAN
BeOne Medicines
ASHLEY JAKSA
Pedestal Health
16:50 – End of Day 1 Sessions & Chairperson’s Closing Remarks
17:00 – 18:15 – Joint Networking Drinks Reception — Main Exhibition Hall
RWD / RWE
14:30 – What market access leaders need to know about trends in rare disease market access strategy
- Rare disease therapies require a different market access strategy. Traditional access models built for high-volume
specialty products often fall short in rare disease, where small patient populations, limited clinical experience, and
individualized care needs require greater coordination and flexibility. - Access planning must go beyond prior authorization. Successful rare disease launches depend on proactivestrategies that address reimbursement, speed-to-therapy, patient support, provider education, and long-termadherence from day one.
- Market access leaders, payers, providers, and rare pharmacy partners must align around measurable patient
outcomes that demonstrate clinical impact, support coverage decisions, and reinforce long-term therapy value.
JAY WEAVER
PANTHERx Rare Pharmacy
15:00 – The Fifth Payer”: Restructuring PRMA & Radically Scaling U.S. Direct‑to‑Patient (DTP) Business Models in the Emerging Data & AI Economy
- The Fifth Payer is the first new U.S. payer category since the 1960s: an economic innovation that reduces drug pricing complexity while improving and scaling pharma DTP business models.
- It’s design structurally removes fundamental PRMA risks—e.g., post‑indication formulary access blockades and automated denials of legitimate claims—via new incentive alignment, governance, guardrails, hyper‑personalization, verifiable ground‑truth data, decentralized registries, and advanced translational sciences.
- Universal Data Income and massively multilateral VBAs reshape equitable access, protocol adherence, and SDoH‑driven outcomes by converting patients, caregivers, communities, and providers into compensated partners producing FDA ‘auditable on‑demand’ RWE.
- PRMA leaders’ pre-competitive, shared-TA collaboration, including with advocacy groups that will connect patients to Fifth Payer public‑privat e utility infrastructures, enables upside next fiscal year and shapes the new market structure before it solidifies.
HEATHER LEIGH FLANNERY
AI MINDSystems Foundation
15:30 – Afternoon Tea/Coffee & Networking
COLLABRATIVE BREAKOUT SESSIONS
16:00 – The round table series
Chairperson for all tables
PETER BARSCHDORFF
Deallus
We have curated 6 distinct roundtable topics, each led by 2 table speakers. The session is designed for maximum cross-pollination of ideas.
The Selection: Look at the table numbers and topics listed below. Choose the theme most relevant to your interest.
The Format: Each table will host a focused, 60 minute-deep dive.
The Flow: Take a seat at your first chosen table. The table speakers will kick off with a brief prompt followed by an open-floor discussion. You have the option to stay put to go deeper or rotate to a different table to gain a new perspective.
Participation Guidelines
Lean In: These sessions thrive on your input. If you are comfortable,
feel free to discuss on your “work-in-progress” thoughts.
Keep it Brief: With limited time, aim for “concise contributions” to ensure everyone at the table has a voice.
Connect: Keep your business cards or digital QR codes ready—these tables are where the best partnerships begin.
Note: Seating is first-come, first-served. If a table is full, we encourage you to explore your second-choice topic—you might find an unexpected insight!
Table 1 – Technology & Innovation – AI & Data-Driven
Market Access — Transforming Pricing and
Reimbursement Through Technology
Leveraging AI for pricing optimization and launch sequencing. Integrating real-world data (RWD) to strengthen market access decisions
Table Speakers / Leaders
HEATHER LEIGH FLANNERY
AI MINDSystems Foundation
Derek Tancredi
AccessSync
Table 2 – Market Access & Reimbursement Pathways
HTA strategy and submissions. Payer negotiation approaches. Early access programs. Overcoming access barriers
Table Speakers / Leaders
HANNAH JAVED
Johnson and Johnson
DHARMESH VORA
Abbott
Table 3 – Innovative Contracting & Value-Based
Agreements
How are they negotiated, deployed & operationalised? how terms should be negotiated?
Table Speakers / Leaders
OMAR ALI
Verpora
Table 4 – Government Contracting, Pricing and Reporting
State Drug Price Transparency & Reporting: State-By-State Review of Legal Requirements and Operational Challenges
Table Speakers / Leaders
ROSALIND DAVIS
CSL Vifor
Table 5 – Key Regulatory and Legal Developments
IRA implementation and litigation. Discussion of government efforts and what is the way forward?
Table Speakers / Leaders
14:50 - Re-imagining Dossier Authoring: From Manual Compilation to AI-Assisted Authoring and Lifecycle Management
- AI-driven automation in dossier creation: Transition from time-consuming manual compilation to intelligent automation where AI tools structure, draft, and validate regulatory dossiers using pre-designed templates as per ICH guidelines and real-time data processing.
- Enhanced compliance and efficiency: AI-assisted authoring ensures alignment with global regulatory standards (e.g., EMA, USFDA, CDSCO) by auto-updating changes in guidance and improving accuracy, traceability, and submission timelines.
- Lifecycle intelligence and version management: Integrating AI into the dossier lifecycle enables continuous monitoring, smart version control, and predictive updates across product changes, fostering a fully connected regulatory ecosystem.
MANASA KASIVAJJULA
CEO and Co-Founder
DeepForrest.ai (A CtrlS Company)
17:00 – Closing remarks by chairperson and End of day 01
conference
17:05 – Networking Drinks
Coffee and registration — Opportunity to meet and network with colleagues
09:00 Chairperson's Opening Remarks
IP PROTECTION
09:10 – International Harmonization of Pharmaceutical IP Protection: U.S. Leadership, Global Alignment & Future Opportunities
- The evolving global landscape of pharmaceutical IP protection.
- Key strengths of the U.S. IP system and lessons for other countries.
- Opportunities for the U.S. to further strengthen innovation and access.
- Advancing global harmonization through collaboration and balanced IP policies.
COKE MORGAN STEWART
(Former) United States Patent & Trademark Office
IP PROTECTION
09:10 – International Harmonization of Pharmaceutical IP Protection: U.S. Leadership, Global Alignment & FutureOpportunities
PETER BARSCHDORFF
Deallus
HTA
09:30 – New Developments and Trends of Heath Technology Assessment (HTA) Around World
- New development of HTA in EU, US and around the world
- Reimbursement and regulatory agencies are collaborating and bringing value-based decisions.
- Updates of EU’s new HTA Regulation, Joint Clinical Assessment (JCA) utilize the Population, Intervention, Comparator, and Outcome (PICO) framework to define the scope of health technology’s evaluation.
- Incorporating market access and HEOR evidence generations into pricing and reimbursement strategy
- Developing successful market access, pricing, and reimbursement strategies. Maximize the access of new products to patients
BOXIONG TANG
Ascentage Pharma
BRAND PROTECTION
10:00 - Keynote Panel Discussion: Brand Protection Strategies for Tomorrow – Emerging Markets, Evolving Threats, Breaking Barriers, Building Trust
Moderator
OMAR ALI
Verpora
Panellists
JEFF COLLINS
Abbvie
CHANEL BRIGGINS
Authentic Brands Group
UMANG SHASTRI
Ferring Pharmaceuticals
10:50 – Morning Networking Coffee/Tea & Discussion Break
IP RISKS – VENDORS / PARTNERSHIPS
11:20 – Panel Discussion - From Vendors to Ventures: How to Identify, Mitigate & Master Intellectual Property risks that can’t be missed
Moderator
JENNIFER BUCHANAN
Oracle
Panellists
COLIN SANDERCOCK
Cue Biopharma
KIM ROBIN JESSUM
Heraeus Medical Components
MARGARET TURCHINSKI
U.S. Customs and Border Protection
SUMIT ARORA
Tesla
12:10 - Topic TBC
AMIT PATEL
Indegene
DAKSHA GUPTA
Indegene
NEXT-GEN BRAND SECURITY
13:40 – Panel Discussion – Technology’s Role in Safeguarding Brands - The Digital Shield13:40 – Panel Discussion – Technology’s Role in Safeguarding Brands - The Digital Shield
Moderator
CHERYL ROCHE ALEXANDER
UCB (Former)
Panellists
SUVENDU MOHANTY
(Former) Amazon
JASON ALAN SNYDER
Artists & Robots
BOXIONG TANG
Ascentage Pharma
DIEGO CORTINA DE LA FUENTE
Takeda
DIEGO CORTINA DE LA FUENTE
Takeda
JOAQUIN MOULD
CSL Seqirus
FUTURE PROOF YOUR IP
14:20 – Mastering Licensing & IP Management: Steering clear of legal landmines
- Drafting rock-solid licensing deals
- Spotting and avoiding costly legal traps
- Winning negotiation strategies for partnerships
- Managing global IP portfolios effectively
- Must-have clauses for every contract
- Overcoming cross-border licensing hurdles
- Future-proofing your IP strategy
MATTHEW FENSELAU
Nanoramic Laboratories
FIGHT THE FAKES
15:30 – Strengthening Brand Protection: Emerging Strategies to Combat Counterfeiting, Fraud & Enforcement Gaps
- Mapping today’s global counterfeit and fraud landscape
- Identifying high-risk markets and emerging threat zones
- Smarter enforcement strategies for cross-border challenges
- How to partner effectively with customs and regulators
- Consumer education as a frontline defence tool
- Key legal shifts shaping enforcement opportunities
- Future-proofing brand security through innovation
WILLIAM MANSFIELD
ABRO Industries
IP LAW – REGULATIONS
16:00 - Panel Discussion – Future of Intellectual Property Law: Adapting Regulations to safeguard brands in a global market
Moderator
WILLIAM MANSFIELD
ABRO Industries
Panellists
MARY PENN
Verizon
CAROLINE PINKSTON
HP
BOXIONG TANG
Ascentage Pharma
DIEGO CORTINA DE LA FUENTE
Takeda
DIEGO CORTINA DE LA FUENTE
Takeda
JOAQUIN MOULD
CSL Seqirus
16:50 – End of Day 1 Sessions & Chairperson’s Closing Remarks
17:00 – 18:15 – Joint Networking Drinks Reception — Main Exhibition Hall
09:00 – Chairperson Opening Remarks
JUSTIN McELFRESH
Ten Count Consulting
JAMES HART
Drug Enforcement Administration
HTA
09:50 –Topic TBC
- New development of HTA in EU, US and around the world
- Reimbursement and regulatory agencies are collaborating and bringing value-based decisions.
- Updates of EU’s new HTA Regulation, Joint Clinical Assessment (JCA) utilize the Population, Intervention, Comparator, and Outcome (PICO) framework to define the scope of health technology’s evaluation.
- Incorporating market access and HEOR evidence generations into pricing and reimbursement strategy
- Developing successful market access, pricing, and reimbursement strategies. Maximize the access of new products to patients
ANTHONY OROSZ
U.S. Customs and Border Protection
10:20 – Solution Provider Showcase Presentation
10:40 –Morning Networking Coffee, Tea & Discussion Break
HTA
09:30 – New Developments and Trends of Heath Technology Assessment (HTA) Around World
- New development of HTA in EU, US and around the world
- Reimbursement and regulatory agencies are collaborating and bringing value-based decisions.
- Updates of EU’s new HTA Regulation, Joint Clinical Assessment (JCA) utilize the Population, Intervention, Comparator, and Outcome (PICO) framework to define the scope of health technology’s evaluation.
- Incorporating market access and HEOR evidence generations into pricing and reimbursement strategy
- Developing successful market access, pricing, and reimbursement strategies. Maximize the access of new products to patients
BOXIONG TANG
Ascentage Pharma
SERIALIZATION, TRACK & TRACE
11:10-Keynote Panel Discussion: Reinventing Pharma Security - The Next Evolution of Serialization & Track-and-Trace. Challenges, Compliance & Future Innovation
Moderator
OMAR ALI
Verpora
Panellists
PAULE BELONY
AstraZeneca
ASMITA KHANOLKAR
Breath Therapeutics
UMANG SHASTRI
Ferring Pharmaceuticals
12:00–Solution Provider Showcase Presentation
AMIT PATEL
Indegene
DAKSHA GUPTA
Indegene
12:30 – Networking luncheon
DSCSA
13:30 – DSCSA in Action: Industry Challenges, Lessons Learned & Preparing for the Next Phase
- Exploring real-world DSCSA implementation challenges and practical lessons learned from the field
- Understanding the impact of the NDC 12-digit rule and what it means for manufacturers, distributors, and dispensers
- Assessing current industry progress, collaboration efforts, and the growing role of support forums in compliance readiness
- Strategic steps organizations can take now to strengthen serialization, data exchange, and supplychain preparedness for future requirements
MANISH GARG
Hikma Pharmaceuticals
DIGITAL FUTURE OF PHARMA SUPPLY CHAIN
14:00 - The Tech -Driven Pharma Supply Chain: Innovation Beyond Compliance Through AI, Data & Digital Innovation
Moderator
STEPHEN FRAMIL
Ai1Y
Panellists
MANISH GARG
Hikma Pharmaceuticals
SRIMAN BANERJEE
Takeda
STEPHEN WING
MilliporeSigma
MANISH SHASHI
Merck
MICHAEL STEPANOVIC
UNC Eshelman
COLLABORATING FOR ACCESS
14:20 – Keynote Panel Discussion: Stronger Together: Bridging industry, payers, and patients for better access. Powering access through collaboration
Moderator
CHERYL ROCHE ALEXANDER
UCB (Former)
Panellists
DIVAY MOR,
Sun Pharma
JOAQUIN MOULD
CSL Seqirus
BOXIONG TANG
Ascentage Pharma
DIEGO CORTINA DE LA FUENTE
Takeda
DIEGO CORTINA DE LA FUENTE
Takeda
JOAQUIN MOULD
CSL Seqirus
14:50 – 15:00 – Closing Remarks by Chairperson & Official End of the conference
15:15 – Afternoon Tea/Coffee & End of the conference
Our Partners
“We extend our sincere gratitude to the following organizations for their vital role in advancing the future of global drug safety. Their generous support, technical expertise, and dedication are the driving force behind the success of the 10th Annual Pharma Pricing, Reimbursement & Market Access USA 2026 summit. Together, we are fostering the innovation and collaboration needed to safeguard patients worldwide.”
THOUGHT LEADER
Key Partners
Supported - By Partner
Thought Leader
Lanyard Partner
Event Venue
Washington , USA
Get Involved
Networking App
Kindly Note!
Access to view and connect with other attendees through our mobile app will be enabled closer to the conference date.
Bookings
Pharma Anti-Counterfeiting, Serialization & Supply Chain Security (2 Days)
Super Early Bird
1 Delegate
Valid till 12 Oct
$ 799
All-Access Pass – 1 Person Access to Track A sessions both days | Dec 2–3, 2026
Strategic Coverage – Single Perspective
Networking Platform – Full Access
Innovation Insights – from global industry leaders
Digital Resource Hub – Included
Professional Certificate – 1 Certificate
Best For – Solo Professionals
Most Popular
Pharma Anti-Counterfeiting, Serialization & Supply Chain Security (2 Days)
Super Early Bird
3 Delegates (3 for 2)
Valid till 12 Oct
Bring the whole team and save $ 799 instantly
$ 1,598
All-Access Pass – 3 People Access to Track A sessions both days | Dec 2–3, 2026
Strategic Coverage – Divide & Conquer All Sessions
Networking Platform – Full Access for the Entire Team
Innovation Insights – from global industry leaders
Digital Resource Hub – Included
Professional Certificate – 3 Certificates
Best For – Corporate Teams & Decision Makers
Brand & IP Protection Summit (1 Day)
Super Early Bird
1 Delegate
Valid till 12 Oct
$ 499
All-Access Pass – 1 Person – Dec 2, 2026 ONLY | Access to Track B sessions on Day 1 only
Strategic Coverage – Single Perspective
Networking Platform – Full Access
Innovation Insights – from global industry leaders
Digital Resource Hub – Included
Professional Certificate – 1 Certificate
Best For – Solo Professionals
Most Popular
Brand & IP Protection Summit (1 Day)
Super Early Bird
3 Delegates (3 for 2)
Valid till 12 Oct
Bring the whole team and save $ 499 instantly
$ 998
All-Access Pass – 3 People – Dec 2, 2026 ONLY | Access to Track B sessions on Day 1 only
Strategic Coverage – Divide & Conquer All Sessions
Networking Platform – Full Access for the Entire Team
Innovation Insights – from global industry leaders
Digital Resource Hub – Included
Professional Certificate – 3 Certificates
Best For – Corporate Teams & Decision Makers
Accommodation
We have secured special room rates for our conference participants who wish to stay at the conference venue hotel “Wyndham Boston Beacon Hill Hotel” during the conference dates.
Once you confirm your participation, our operations team will share the room reservation details along with the booking deadline and the special rates we’ve arranged.
Event Testimonials
United Kingdom
Block 3, 86 Coombe Road
Croydon CR0 5RA
London, UK
Asia
Plot No – 07 – 2nd Floor
Ekambaram Industrial Estate
Alapakkam, Porur Chennai,
India – 600 116
Download App